ClinicalTrials.govpublic full text
Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis
urinary bladder, neurogenic, multiple sclerosis, botulinum toxin, neurogenic bladder, anticholinergic drugs, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 877034
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.